Randomized pilot vs usual dose of lenalidomide dose reduction in patients with relapsed multiple myeloma who have reached maximum response. [No Ensayo piloto aleatorizado de dosis habitual de lenalidomida vs reducción de dosis en pacientes con mieloma múltiple en recaída que han alcanzado máxima respuesta]
Latest Information Update: 22 Jul 2017
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 09 Jul 2015 New trial record